Vitalhub reported Q2 2026 revenue of CAD 31.7M, up 33% YoY, and said annual recurring revenue (ARR) surpassed CAD 100M for the first time. The strong top-line growth and ARR milestone point to accelerating recurring revenue momentum. Overall read-through is modestly positive for the stock.
Vitalhub reported Q2 2026 revenue of CAD 31.7M, up 33% YoY, and said annual recurring revenue (ARR) surpassed CAD 100M for the first time. The strong top-line growth and ARR milestone point to accelerating recurring revenue momentum. Overall read-through is modestly positive for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
